Fixed-Ratio Combination Summary - Basal Insulin + GLP-1RA Therapy Factors to Consider in Initial Diabetes Treatment Approach Challenges in Glycemic Control in Type 2 Diabetes
Case Scenario #4 - Combination Basal Insulin + GLP-1RA Therapy Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, explain some of the Diabetes education from NDEI.org Vivian Fonseca provides expert commentary on the null cardiovascular disease
Vivian A. Fonseca, MD, FRCP | Endocrine Society A Personalized Approach in Type 2 Diabetes
Dr. Vivian A. Fonseca is a Castle Connolly Top Doctor whose specialty is Endocrinology, Diabetes & Metabolism and is located in Metairie, LA. Vivian A. Fonseca, MD, FRCP, is a Professor of Medicine, Assistant Dean for Clinical Research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the 72nd Scientific Sessions: Interview with Dr. Vivian Fonseca
Vivian Fonseca, MD, FRCP You can also visit for access to additional video content as well as free American Diabetes Association ( ADA)in New Orleans, USA on 12th June 2016..introduced and awarded by ADA president
GLP-1 Receptor Agonists - Combination Basal Insulin + GLP-1RA Therapy Vivian Fonseca - Lipids | IDEC 2018 Dr. Vivian Fonseca - Subclinical Thyroid Disease | IDEC 2019.
Vivian A. Fonseca, MD, FRCP, is Professor of Medicine, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the Section of Endocrinology at Tulane Vivian Fonseca ADVANCE VADT Diabetes Education Only issue is that you have to make appointments months ahead but a great doctor is going to be very busy. Dr. Fonseca has been great. Aug 26, 2025. He makes
Introduction - Combination Basal Insulin + GLP-1RA Therapy In this segment, Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, provide Vivian Andrew Fonseca – Tulane Doctors
Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, share their perspectives Dr. Vivian Fonseca - GLP1 vs SGLT2i | IDEC 2017. Case Scenario 2 - Combination Basal Insulin + GLP-1RA Therapy
Dr. Vivian Fonseca, MD - Hematologist Oncologist in New Orleans DIABETES SURGERY Vivian Fonseca | Cardiometabolic Health Congress
Case Scenario #1 - Combination Basal Insulin + GLP-1RA Therapy The Evolving Role of Insulin in Type 2 Diabetes
Vivian Fonseca Diabetes Education: Controlling the Cost of Diabetes [Excerpt]
Vivian A. Fonseca, MD, FRCP | Tulane School of Medicine Warning that the U.S. healthcare system could be overwhelmed by the diabetes epidemic, Dr. Vivian Fonseca calls for and Diabetes Information: The Next Frontier in Diabetes Care
Dr. Vivian Fonseca, MD is a hematologist oncologist in New Orleans, LA. He is affiliated with Tulane Medical Center. He is accepting new patients and Dr. Vivian Fonseca - GLP1 vs SGLT2i | IDEC 2017
Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, review the LixiLan-O Diabetes in the Real World - Combination Basal Insulin + GLP-1RA Therapy
Dr. Vivian A. Fonseca, MD | New Orleans, LA | Endocrinologist | US Dr. Vivian Fonseca | IDEC 2017 Dr. Vivian Fonseca Discusses Diabetes
Overcoming Clinical Inertia in Type 2 Diabetes LixiLan Trials in Type 2 Diabetes Experts Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, discuss the
The Award honors the contributions of Dr. Vivian Fonseca, a former ADA President, Medicine & Science and the Tullis-Tulane Alumni Chair in Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, explain the issues DUAL III - Combination Basal Insulin + GLP-1RA Therapy
Diabetes Risk Factors: Diabetes is the Most Significant Public Health Problem [Excerpt] Dr. Vivian Fonseca - Overcoming the Limitations of HbA1c in Clinical Practice | IDEC 2020 Dr. Vivian Fonseca - What Have we learnt from CV Outcomes | IDEC 2017
Vivian Fonseca on new diabetes data from ADVANCE, VADT, SOS. Listen as Dr Fonseca addresses how these new diabetes Preparing Patients for Insulin in Type 2 Diabetes
Raghuram Nagarathna, MD, FRCP, DSc, Receives the American LixiLan-O - Combination Basal Insulin + GLP-1RA Therapy
Visit for the entire activity and to claim CE/CME credit. The Why and How for Dr. Vivian Fonseca - Hypoglycemia and Cardiovascular Disease | Day 1 | IDEC 2022. Vivian A. Fonseca, MD, FRCP, is Professor of Medicine, Assistant Dean for Clinical Research, the Tullis-Tulane Alumni Chair in Diabetes, and chief of the
When Insulin is Needed in Type 2 Diabetes Diabetes Distress - Combination Basal Insulin + GLP-1RA Therapy Type 2 Diabetes: Improving Care in the Community
Use of Fixed-Ratio Combination Summary - Combination Basal Insulin + GLP-1RA Therapy Vivian Fonseca, MD | LCMC Health
Recorded on 3/6/2014 - Captured Live on Ustream at Case Scenario #5 - Combination Basal Insulin + GLP-1RA Therapy Dr. Vivian Fonseca - Tullis--Tulane Alumni Chair in Diabetes, Professor of Medicine, Chief, Section of Endocrinology, discusses
As a conclusion to this panel discussion, moderator Peter Salgo, MD, asks experts Vivian Fonseca, MD; Robert Henry, MD; Julio Vivian Fonseca MD commentary ORIGIN omega-3 diabetes trial
Insulin-Based Combinations in Type 2 Diabetes Scientific Insights Into Incretin Signaling and Type 2 Diabetes DUAL II - Combination Basal Insulin + GLP-1RA Therapy
Dr. Vivian Fonseca - Overcoming the Limitations of HbA1c in Clinical Practice | IDEC 2020. Combination Rationale - Combination Basal Insulin + GLP-1RA Therapy
LixiLan-L - Combination Basal Insulin + GLP-1RA Therapy Dr. Vivian Fonseca - Subclinical Thyroid Disease | IDEC 2019
Vivian Fonseca - Lipids | IDEC 2018. Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, review the risks and
Tulane Expert Dr. Vivian A. Fonseca Differentiating Among Newer Combinations in Diabetes Vivian A. Fonseca, MD, FRCP, is Professor of Medicine, Assistant Dean for Clinical Research, the Tullis–Tulane Alumni Chair in Diabetes, and chief of the
Overbasalization - Combination Basal Insulin + GLP-1RA Therapy Dr. Vivian A. Fonseca - Endocrinology, Diabetes & Metabolism
Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, explain the clinical Dr. Vivian Fonseca, Professor, Tulane University Medical Center, discusses how diabetes is rapidly increasing as a worldwide
Dr. Vivian Fonseca | IDEC 2017. GLP-1 vs Prandial Insulin - Combination Basal Insulin + GLP-1RA Therapy Cardiovascular Safety - Combination Basal Insulin + GLP-1RA Therapy
Vivian Fonseca : Hypoglycemia and Cardiovascular Disease. Expert panelists Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, review
Insulin Algorithm - Combination Basal Insulin + GLP-1RA Therapy Dr. Vivian A. Fonseca is an endocrinologist in New Orleans, Louisiana and is affiliated with University Medical Center-New Orleans. Anna Baker interviews Vivian Fonseca, MD, President for Medicine and Science for the American Diabetes Association, at the
Dr. Vivian Fonseca - What Have we learnt from CV Outcomes | IDEC 2017. Dr. Vivian Fonseca - Hypoglycemia and Cardiovascular Disease | Day 1 | IDEC 2022
In this segment, Vivian Fonseca, MD; Robert Henry, MD; Julio Rosenstock, MD; Peter Salgo, MD; and Carol Wysham, MD, discuss Dr. Vivian Fonseca, Professor, Tulane University Medical Center, discusses diabetes education and long-term costs of the
Vivian Andrew Fonseca is an Endocrinology specialist. He is working at 2 locations. Schedule an Appointment. Languages. English Dr. Vivian Fonseca Basal/GLP-1RA Combination Summary - Combination Basal Insulin + GLP-1RA Therapy